Publicaciones en colaboración con investigadores/as de University of Oslo (8)

2024

  1. International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma

    The Lancet Oncology, Vol. 25, Núm. 5, pp. e205-e216

2023

  1. Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

    Cancer Discovery, Vol. 13, Núm. 11, pp. 2370-2393

  2. Cobimetinib Alone and Plus Venetoclax With/Without Atezolizumab in Patients With Relapsed/Refractory Multiple Myeloma

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 23, Núm. 1, pp. e59-e70

2022

  1. ADAMTSL3 knock-out mice develop cardiac dysfunction and dilatation with increased TGFβ signalling after pressure overload

    Communications Biology, Vol. 5, Núm. 1

2020

  1. Recent Advancements in Hematology: Knowledge, Methods and Dissemination, Part 1

    HEMATO

2019

  1. EU-OPENSCREEN: A Novel Collaborative Approach to Facilitate Chemical Biology

    SLAS Discovery, Vol. 24, Núm. 3, pp. 398-413

2014

  1. Awareness and understanding of cancer immunotherapy in Europe

    Human Vaccines and Immunotherapeutics, Vol. 10, Núm. 7, pp. 1828-1835

  2. Therapeutic vaccines for cancer: An overview of clinical trials

    Nature Reviews Clinical Oncology, Vol. 11, Núm. 9, pp. 509-524